Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0FL0R
|
|||
| Former ID |
DIB003296
|
|||
| Drug Name |
ALS-L1023
|
|||
| Indication | Obesity [ICD-11: 5B81; ICD-10: E66; ICD-9: 278] | Phase 3 | [1] | |
| Company |
Angiolab Inc
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01872182) Efficacy and Safety Study of ALS-L1023 in Patients With Abdominal Obesity of Metabolic Syndrome. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.